Verheyden Geert S A F, Weerdesteyn Vivian, Pickering Ruth M, Kunkel Dorit, Lennon Sheila, Geurts Alexander C H, Ashburn Ann
Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008728. doi: 10.1002/14651858.CD008728.pub2.
Falls are one of the most common medical complications after stroke with a reported incidence of 7% in the first week after stroke onset. Studies investigating falls in the later phase after stroke report an incidence of up to 73% in the first year post-stroke.
To evaluate the effectiveness of interventions aimed at preventing falls in people after stroke.
We searched the trials registers of the Cochrane Stroke Group (November 2012) and the Cochrane Bone, Joint and Muscle Trauma Group (May 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library 2012, Issue 5, MEDLINE (1950 to May 2012), EMBASE (1980 to May 2012), CINAHL (1982 to May 2012), PsycINFO (1806 to May 2012), AMED (1985 to May 2012) and PEDro (May 2012). We also searched trials registers, checked reference lists and contacted authors.
Randomised controlled trials of interventions where the primary or secondary aim was to prevent falls in people after stroke.
Review authors independently selected studies for inclusion, assessed trial quality, and extracted data. We used a rate ratio and 95% confidence interval (CI) to compare the rate of falls (e.g. falls per person year) between intervention and control groups. For risk of falling we used a risk ratio and 95% CI based on the number of people falling (fallers) in each group. We pooled results where appropriate.
We included 10 studies with a total of 1004 participants. One study evaluated the effect of exercises in the acute and subacute phase after stroke but found no significant difference in rate of falls (rate ratio 0.92, 95% CI 0.45 to 1.90, 95 participants). The pooled result of four studies investigating the effect of exercises on preventing falls in the chronic phase also found no significant difference for rate of falls (rate ratio 0.75, 95% CI 0.41 to 1.38, 412 participants).For number of fallers, one study examined the effect of exercises in the acute and subacute phase after stroke but found no significant difference between the intervention and control group (risk ratio 1.19, 95% CI 0.83 to 1.71, 95 participants). The pooled result of six studies examining the effect of exercises in the chronic phase also found no significant difference in number of fallers between the intervention and control groups (risk ratio 1.02, 95% CI 0.83 to 1.24, 616 participants).The rate of falls and the number of fallers was significantly reduced in two studies evaluating the effect of medication on preventing falls; one study (85 participants) compared vitamin D versus placebo in institutionalised women after stroke with low vitamin D levels, and the other study (79 participants) evaluated alendronate versus alphacalcidol in hospitalised people after stroke.One study provided single lens distance glasses to regular wearers of multifocal glasses. In a subgroup of 46 participants post-stroke there was no significant difference in the rate of falls (rate ratio 1.08, 95% CI 0.52 to 2.25) or the number of fallers between both groups (risk ratio 0.74, 95% CI 0.47 to 1.18).
AUTHORS' CONCLUSIONS: There is currently insufficient evidence that exercises or prescription of single lens glasses to multifocal users prevent falls or decrease the number of people falling after being discharged from rehabilitation following their stroke. Two studies testing vitamin D versus placebo and alendronate versus alphacalcidol found a significant reduction in falls and the number of people falling. However, these findings should be replicated before the results are implemented in clinical practice.
跌倒为卒中后最常见的医学并发症之一,据报道,卒中发病后第一周的发生率为7%。关于卒中后晚期跌倒情况的研究表明,卒中后第一年的发生率高达73%。
评估旨在预防卒中后患者跌倒的干预措施的有效性。
我们检索了Cochrane卒中小组试验注册库(2012年11月)和Cochrane骨、关节与肌肉创伤小组试验注册库(2012年5月)、2012年第5期《Cochrane图书馆》中的Cochrane系统评价数据库、MEDLINE(1950年至2012年5月)、EMBASE(1980年至2012年5月)、CINAHL(1982年至2012年5月)、PsycINFO(1806年至2012年5月)、AMED(1985年至2012年5月)和PEDro(2012年5月)。我们还检索了试验注册库,查阅了参考文献列表并联系了作者。
干预措施的随机对照试验,其主要或次要目的是预防卒中后患者跌倒。
综述作者独立选择纳入研究、评估试验质量并提取数据。我们使用率比和95%置信区间(CI)比较干预组和对照组之间的跌倒率(如每人每年跌倒次数)。对于跌倒风险,我们根据每组跌倒人数(跌倒者)使用风险比和95%CI。我们在适当情况下合并结果。
我们纳入了10项研究,共1004名参与者。一项研究评估了卒中后急性期和亚急性期运动的效果,但未发现跌倒率有显著差异(率比0.92,95%CI 0.45至1.90,95名参与者)。四项研究调查运动对预防慢性期跌倒效果的汇总结果也未发现跌倒率有显著差异(率比0.75,95%CI 0.41至1.38,412名参与者)。对于跌倒者人数,一项研究检查了卒中后急性期和亚急性期运动的效果,但未发现干预组和对照组之间有显著差异(风险比1.19,95%CI 0.83至1.71,95名参与者)。六项研究检查慢性期运动效果的汇总结果也未发现干预组和对照组之间跌倒者人数有显著差异(风险比1.02,95%CI 0.83至1.24,616名参与者)。在两项评估药物预防跌倒效果的研究中,跌倒率和跌倒者人数显著降低;一项研究(85名参与者)比较了维生素D与安慰剂对卒中后维生素D水平低的机构化女性的影响,另一项研究(79名参与者)评估了阿仑膦酸钠与阿法骨化醇对卒中后住院患者的影响。一项研究为多焦点眼镜的常规佩戴者提供单焦点眼镜。在46名卒中后参与者的亚组中,两组之间的跌倒率(率比1.08,95%CI 0.52至2.25)或跌倒者人数均无显著差异(风险比0.74,95%CI 0.47至1.18)。
目前尚无充分证据表明运动或为多焦点眼镜使用者开具单焦点眼镜可预防跌倒或减少卒中后康复出院后的跌倒人数。两项比较维生素D与安慰剂以及阿仑膦酸钠与阿法骨化醇的研究发现跌倒及跌倒人数显著减少。然而,在将这些结果应用于临床实践之前,应重复这些研究结果。